Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity.
Horacek
J M
JM
Tichy
M
M
Pudil
R
R
Jebavy
L
L
D000328:Adult; D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D024981:Glycogen Phosphorylase / Q000097:blood*; D006331:Heart Diseases / Q000097:blood* / Q000139:chemically induced / Q000175:diagnosis*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D015996:Survival Rate
D018943:Anthracyclines; D000970:Antineoplastic Agents; D015415:Biomarkers; D024981:Glycogen Phosphorylase; C528446:glycogen phosphorylase BB, human